VEGFA and infection: Bevacizumab, by inhibiting VEGF, disrupts angiogenesis – a critical component of normal wound healing – thereby impairing the delivery of inflammatory cells, nutrients, and oxygen to the wound site.[15] The unique properties of sugar, including its ability to reduce infection risk, promote fibroblast proliferation, accelerate granulation tissue formation, create a moist environment that favors angiogenesis,[7,10–12] make it a promising option for enhancing wound healing under challenging conditions.